Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases.

Santos S, Ramírez M, Miranda E, Reyes N, Martínez O, Acosta-Santiago M, Rivera JM, Otero M.

J Immunol Res. 2019 May 22;2019:3409371. doi: 10.1155/2019/3409371. eCollection 2019.


Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA.

Ramírez M, Santos S, Martínez O, Rodríguez R, Miranda E, Ramos-Perez WD, Otero M.

Vaccine. 2018 Apr 5;36(15):2049-2055. doi: 10.1016/j.vaccine.2018.02.033. Epub 2018 Mar 7.


Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.

Martínez O, Bravo Cruz A, Santos S, Ramírez M, Miranda E, Shisler J, Otero M.

Vaccine. 2017 Oct 20;35(44):6007-6014. doi: 10.1016/j.vaccine.2017.05.091. Epub 2017 Jun 16.


A Quantitative Proteomics Approach to Clinical Research with Non-Traditional Samples.

Licier R, Miranda E, Serrano H.

Proteomes. 2016 Oct 17;4(4). pii: E31. doi: 10.3390/proteomes4040031.


Immunomodulatory Response Triggered by the Alkaloids, 3-Amino-7-Benzylbenzimidazo[3,2-a] Quinolinium Chloride (ABQ-48) and 3-Nitro-7-Benzylbenzimidazo [3,2-a] Quinolinium Chloride (NBQ-48).

Otero M, Zayas B, Miranda E, Velez C, Hernandez WJ, Rivera LA, Cox O.

J Cancer Res Ther Oncol. 2015 May 4;1. doi: 10.17303/jcrto.2015.103.


Immunomodulator-based enhancement of anti smallpox immune responses.

Martínez O, Miranda E, Ramírez M, Santos S, Rivera C, Vázquez L, Sánchez T, Tremblay RL, Ríos-Olivares E, Otero M.

PLoS One. 2015 Apr 13;10(4):e0123113. doi: 10.1371/journal.pone.0123113. eCollection 2015.

Supplemental Content

Loading ...
Support Center